Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 249 results for "cadila health"

​Zydus Cadila acquires six brands from MSD
Franchise India

Cadila arm acquires six brands from MSD pharma

Singapore: Indian pharma giant Cadila healthcare's arm Zydus Healthcare has acquired six brands from MSD Pharmaceuticals India Pvt. Ltd, the local arm of US-based Merck & Co Inc, for distribution in the Indian market. Cadila said in a statement here ... Bio Spectrum Asia, 2 weeks ago
Zydus Cadila open for buyouts in the US Smart Investor, 1 day ago
Zydus acquires six brands from US pharma player MSD Hindu Business Line, 3 weeks ago

6 images for cadila health

Money Control, 1 day ago
Sahara, 1 month ago
Money Control, 2 months ago
Money Control, 2 months ago
Money Control, 1 month ago
Money Control, 4 months ago
Money Control

Zydus Cadila gets USFDA nod for chemotherapy drug

Zydus Cadila has received approval from the US health regulator to market methotrexate tablets, a chemotherapy drug, in the American market. The company has received final approval from the US Food and Drug Administration (USFDA) to market the drug, Zydus ...
 Business Line1 day ago Cadila Healthcare gets USFDA nod for metronidazole tablets  News Track India1 month ago Zydus Cadila Gets USFDA Nod For Anti-Infections Tablets  NDTV Profit1 month ago

Cadila Healthcare misbranded Saroglitazar, says US FDA

MUMBAI: Zydus Discovery DMCC, a research subsidiary of Cadila Healthcare, has been pulled up by the US FDA for misbranding Saroglitazar, its drug used in India to treat diabetic dyslipidemia and hypertriglyceridemia, in a promotional YouTube video. ...
 Economic Times3 weeks ago US FDA pulls up Cadila for misbranding drug  Economic Times3 weeks ago An Analysis Of FDA FY2016 Drug GMP Warning Letters  Pharmaceutical Online3 days ago

Buy MM Financial, Mindtree; sell Cadila Health: Ashwani Gujral

Ashwani Gujral of suggests buying Cholamandalam Investment, MM Financial Services and Mindtree and advises selling Cadila Healthcare.
 Money Control3 weeks ago Sell Shriram Transport, Sun Pharma, Cadila Health: Gujral  Money Control1 month ago Buy NIIT Tech, Cadila Health: Ashwani Gujral  Money Control1 month ago

Sun Pharma, Cadila Healthcare recall products from US market

Zydus Pharmaceuticals USA is recalling 2,472 units of Bupropion Hydrochloride extended release tablets manufactured by Ahmedabad-based Cadila Healthcare New Delhi: The US-based subsidiaries of two domestic drug firms—Sun Pharma and Cadila ...
 Livemint.com1 month ago Zydus recalls over 16,000 bottles of anti-depressant drug in US  Livemint.com3 weeks ago Zydus recalls over 16k bottles of anti-depressant drug in US  Smart Investor3 weeks ago

Sell Divis Labs, Cadila Health, Adani Ports: CA Rudramurthy BV

CA Rudramurthy BV, Research head at Vachana Investments recommends selling Divis Labs, Cadila Healthcare and Adani Ports.
 Money Control3 weeks ago
Money Control

Cadila's 20k bottles of anti-depressant recalled in US

Over 20,500 bottles of anti- depressant Bupropion Hydrochloride extended release tablets made by Cadila Healthcare are being recalled by Amerisource Health Services for failed dissolution specifications. The reason for the recall is "failed ...
 Business Standard1 month ago Over 20,500 Bottles Of Cadila's Anti-Depressant Recalled In US: Report  NDTV Profit1 month ago

Buy Glenmark, Greenply, Cadila Health, Vedanta: Mitesh Thacker

Mitesh Thacker of is of the view that one can buy Glenmark Pharma, Greenply, Cadila Healthcare and Vedanta.
 Money Control2 months ago Buy Dish TV, Cadila Health, AB Fashion; sell Infosys: Thacker  Money Control2 months ago
Money Control

Cadila Health Q2 profit seen up 2%, margin may shrink on biz mix

Pharma company Cadila Healthcare is expected to report a 2.3 percent growth in second quarter profit at Rs 399.83 crore and 0.7 percent rise in revenue at Rs 2,477.2 crore on yearly basis, according to average of estimates of analysts polled by CNBC-TV18.
 Money Control2 months ago Cadila Health Q2 profit tanks 29% on weak margin; revenue flat  Money Control2 months ago

Sensex Trades in the Red; Metal Stocks Witness Selling - Thursday, Jan 19

at 07:42 AM EST Stocks of pharma firm Cadila Healthcare were in focus today, as the company announced that it has received approval from the US health regulator - (FDA) to market methotrexate tablets, a chemotherapy drug, on the
 International Business Times13 hours ago Sensex Opens Flat, Cadila Healthcare Slumps 1.7%  Equitymaster.com3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less